PROGYNY INC (PGNY) Stock Price, Quote, News and Overview
NASDAQ:PGNY - Nasdaq - US74340E1038 - Common Stock - Currency: USD
PGNY Quote, Performance and Key Statistics
23.2
-0.68 (-2.85%)
The current stock price of PGNY is 23.2 USD. In the past month the price increased by 5.36%. In the past year, price decreased by -40.01%.
PGNY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 16.71 | 429.24B | ||
| ELV | ELEVANCE HEALTH INC | 11.68 | 89.31B | ||
| HUM | HUMANA INC | 15.81 | 30.87B | ||
| CNC | CENTENE CORP | 8.12 | 28.60B | ||
| MOH | MOLINA HEALTHCARE INC | 12.53 | 15.75B | ||
| HQY | HEALTHEQUITY INC | 35.37 | 9.41B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.53B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.20B | ||
| NEUE | NEUEHEALTH INC | 5.57 | 60.93M |
Related stock screener links
About PGNY
Company Profile
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 563 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
PROGYNY INC
1359 Broadway
New York City NEW YORK 10018 US
CEO: David Schlanger
Employees: 565
Company Website: https://www.progyny.com/
Investor Relations: https://investors.progyny.com/
Phone: 12128883124
PROGYNY INC / PGNY FAQ
What is the stock price of PROGYNY INC today?
The current stock price of PGNY is 23.2 USD. The price decreased by -2.85% in the last trading session.
What is the ticker symbol for PROGYNY INC stock?
The exchange symbol of PROGYNY INC is PGNY and it is listed on the Nasdaq exchange.
On which exchange is PGNY stock listed?
PGNY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PROGYNY INC stock?
16 analysts have analysed PGNY and the average price target is 20.25 USD. This implies a price decrease of -12.7% is expected in the next year compared to the current price of 23.2. Check the PROGYNY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PROGYNY INC worth?
PROGYNY INC (PGNY) has a market capitalization of 1.98B USD. This makes PGNY a Small Cap stock.
How many employees does PROGYNY INC have?
PROGYNY INC (PGNY) currently has 565 employees.
What are the support and resistance levels for PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a support level at 21.92 and a resistance level at 23.21. Check the full technical report for a detailed analysis of PGNY support and resistance levels.
Is PROGYNY INC (PGNY) expected to grow?
The Revenue of PROGYNY INC (PGNY) is expected to grow by 4.94% in the next year. Check the estimates tab for more information on the PGNY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PROGYNY INC (PGNY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PGNY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PGNY, evaluating the profitability, health, valuation and growth aspects
- PROGYNY INC (PGNY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PROGYNY INC (PGNY) Sales and EPS estimates to see what analysts future expectations are.
- PROGYNY INC (PGNY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PROGYNY INC (PGNY) Insider and Institutional Ownership to learn about the owners and their transactions.
- PROGYNY INC (PGNY) Stock Chart to make your own analysis
- PROGYNY INC (PGNY) Latest news and press-releases to stay up to date.
Does PROGYNY INC (PGNY) stock pay dividends?
PGNY does not pay a dividend.
When does PROGYNY INC (PGNY) report earnings?
PROGYNY INC (PGNY) will report earnings on 2025-03-03, after the market close.
What is the Price/Earnings (PE) ratio of PROGYNY INC (PGNY)?
The PE ratio for PROGYNY INC (PGNY) is 40. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 23.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for PGNY.
What is the Short Interest ratio of PROGYNY INC (PGNY) stock?
The outstanding short interest for PROGYNY INC (PGNY) is 15.95% of its float. Check the ownership tab for more information on the PGNY short interest.
PGNY Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PGNY. When comparing the yearly performance of all stocks, PGNY turns out to be only a medium performer in the overall market: it outperformed 63.58% of all stocks.
PGNY Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PGNY. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
PGNY Financial Highlights
Over the last trailing twelve months PGNY reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS increased by 11.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.03% | ||
| ROA | 8.68% | ||
| ROE | 13.17% | ||
| Debt/Equity | 0 |
PGNY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to PGNY. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -9.12% and a revenue growth 4.94% for PGNY